position Q2/2020 Q2/2019 Q1/2020 YoY QoQ Service revenue 1,036.86 537.80 646.34 92.80% 60.42% Gross profit 154.15 76.90 114.91 100.46% 34.14% Other income 1.22 8.39 10.29 -85.48% -88.16% Expenses of sales
like to clarify a significance change of Group’s operation results were summarized as follows 1. Revenue from sales of goods and rendering of services for the year 2019 decreased by 13% compared to the
Change Amount % Change Total Revenues 7,792 7,550 242 3.2% Sales and service income 7,624 7,300 324 4.4% Gains on Exchange rate 69 175 -106 -60.3% Other Income 99 75 24 30.8% Cost of Sales and Services
of 2019. A summary of the Company’s operating performance in the second quarter of 2020 and 2019 is shown in the following table: 2Q20 1Q20 % Change 2Q19 % Change [Amount in Baht Million] Q-o-Q Y-o-Y
27,898 Q1/19 236,732 84,100 22,010 20,368 35,928 Change 23,180 7,393 36 1,659 8,030 % Change 10.85% 9.64% 0.16% 8.86% 28.78% - 50,000 100,000 150,000 200,000 250,000 Revenue Gross profit Selling Admin Net
results for the six-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
following table. (Unit: Million Baht) Q2/2016 Q2/2017 Y-O-Y Change Increase/(Decrease) Note Sales Revenue 213.2 196.4 (7.9%) The company's sales revenue for Q2/2017 was THB 196.4 mn and classified from the
result of the third Quarter ended September 30, 2020 compared with the same period of 2019, the Company had the Revenue from Sale of THB 391.51 Million which was increased by THB 173.92 Million or 79.93
report its operating results as detailed below:- 1. Total revenue The total revenue of the Company and its subsidiaries for the year 2018 was 18,446 million Baht, compared to that of 17,733 million Baht in